These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 1886533)

  • 21. Growth hormone therapy of Turner's syndrome: beneficial effect on adult height.
    Rosenfeld RG; Attie KM; Frane J; Brasel JA; Burstein S; Cara JF; Chernausek S; Gotlin RW; Kuntze J; Lippe BM; Mahoney CP; Moore WV; Saenger P; Johanson AJ
    J Pediatr; 1998 Feb; 132(2):319-24. PubMed ID: 9506648
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Improvement in the longitudinal growth in Ullrich-Turner syndrome with oxandrolone. Function of urinary excretion of steroid hormones].
    Schönberger W; Benes P; Morsches B; Zabel B; Scheidt E
    Dtsch Med Wochenschr; 1982 Jul; 107(26):1008-11. PubMed ID: 6211346
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of oxandrolone on growth and final height in Turner's syndrome.
    Naeraa RW; Nielsen J; Pedersen IL; Sørensen K
    Acta Paediatr Scand; 1990; 79(8-9):784-9. PubMed ID: 2239273
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Three-year results of treatment with growth hormone, alone or associated with oxandrolone, in girls with Turner syndrome. The Kabi Collaborative Study Group.
    Job JC; Landier F
    Horm Res; 1991; 35(6):229-33. PubMed ID: 1819547
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of Turner's syndrome with recombinant human growth hormone (somatrem).
    Lippe B; Rosenfeld RG; Hintz RL; Johanson AJ; Frane J; Sherman B
    Acta Paediatr Scand Suppl; 1988; 343():47-52. PubMed ID: 3057808
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Six-year results of a randomized, prospective trial of human growth hormone and oxandrolone in Turner syndrome.
    Rosenfeld RG; Frane J; Attie KM; Brasel JA; Burstein S; Cara JF; Chernausek S; Gotlin RW; Kuntze J; Lippe BM
    J Pediatr; 1992 Jul; 121(1):49-55. PubMed ID: 1625092
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment outcome in Turner syndrome.
    Parvin M; Roche E; Costigan C; Hoey HM
    Ir Med J; 2004 Jan; 97(1):12, 14-5. PubMed ID: 15055914
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Growth hormone treatment in Turner's syndrome: short and long-term effects on metabolic parameters.
    Haeusler G; Frisch H
    Clin Endocrinol (Oxf); 1992 Mar; 36(3):247-53. PubMed ID: 1563078
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combined therapy with growth hormone and oxandrolone in adolescent girls with Turner syndrome.
    Lu PW; Cowell CT
    J Paediatr Child Health; 1993 Feb; 29(1):40-2. PubMed ID: 8461179
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Treatment of Turner syndrome].
    Ferrández A; Mayayo E; Sanjuan P; Bello E; Labarta JI
    An Esp Pediatr; 1992 Jun; 36 Suppl 50():105-8. PubMed ID: 1416500
    [No Abstract]   [Full Text] [Related]  

  • 31. Growth and puberty in Turner's syndrome.
    Bertelloni S; Baroncelli GI; Fruzzetti F; Spinelli C; Simi P; Saggese G
    J Pediatr Endocrinol Metab; 2003 Mar; 16 Suppl 2():307-15. PubMed ID: 12729409
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hormonal therapy in a patient with a delayed diagnosis of Turner's syndrome.
    Gawlik A; Malecka-Tendera E
    Nat Clin Pract Endocrinol Metab; 2008 Mar; 4(3):173-7. PubMed ID: 18227816
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of oxandrolone and timing of pubertal induction on final height in Turner's syndrome: randomised, double blind, placebo controlled trial.
    Gault EJ; Perry RJ; Cole TJ; Casey S; Paterson WF; Hindmarsh PC; Betts P; Dunger DB; Donaldson MD;
    BMJ; 2011 Apr; 342():d1980. PubMed ID: 21493672
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Final height outcome in girls with Turner syndrome treated with a combination of low dose oestrogen and oxandrolone.
    Bareille P; Massarano AA; Stanhope R
    Eur J Pediatr; 1997 May; 156(5):358-62. PubMed ID: 9177976
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Three-year results of a randomized prospective trial of methionyl human growth hormone and oxandrolone in Turner syndrome.
    Rosenfeld RG; Hintz RL; Johanson AJ; Sherman B; Brasel JA; Burstein S; Chernausek S; Compton P; Frane J; Gotlin RW
    J Pediatr; 1988 Aug; 113(2):393-400. PubMed ID: 3397807
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oxandrolone in girls with Turner's syndrome. A pair-matched controlled study up to final height.
    Joss E; Zuppinger K
    Acta Paediatr Scand; 1984 Sep; 73(5):674-9. PubMed ID: 6385611
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of growth hormone and oxandrolone singly and together on growth rate in girls with X chromosome abnormalities.
    Rudman D; Goldsmith M; Kutner M; Blackston D
    J Pediatr; 1980 Jan; 96(1):132-5. PubMed ID: 7350294
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Results from the first 2 years of a clinical trial with recombinant DNA-derived human growth hormone (somatrem) in Turner's syndrome.
    Rosenfeld RG; Hintz RL; Johanson AJ; Sherman B
    Acta Paediatr Scand Suppl; 1987; 331():59-69. PubMed ID: 3300157
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prospective study confirms oxandrolone-associated improvement in height in growth hormone-treated adolescent girls with Turner syndrome.
    Zeger MP; Shah K; Kowal K; Cutler GB; Kushner H; Ross JL
    Horm Res Paediatr; 2011; 75(1):38-46. PubMed ID: 20733274
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Growth hormone therapy in Turner syndrome. Analysis of long-term results.
    Ranke MB
    Horm Res; 1995; 44 Suppl 3():35-41. PubMed ID: 8719439
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.